Accelerated partial breast irradiation (APBI) is increasingly available approach in adjuvant RT of selected group of the early-stage breast cancer. Accumulating data are showing non-inferiority of both interstitial brachytherapy and external beam radiotherapy via stereotactic body radiotherapy (SBRT). The aim of this single institutional prospective randomized study is to compare the SBRT_APBI with accelerated whole breast irradiation (WBI). The main objective is to evaluate feasibility, safety, tolerance and cosmetic effects of SBRT. Patients with early breast carcinoma after partial mastectomy were screened for eligibility: age ˃ 50, NST histology, size ≤ 2 cm, negative margins ≥ 2 mm, no lymphovascular invasion, ER positive, BRCA negative. Randomization to: surgery bed SBRT (5x 6Gy) and accelerated WBI with tumor bed boost (15x 2.67Gy + 5x 2Gy). 4DCT-based planning, deep inspiration breath hold, daily pre-treatment positioning by cone-beam CT and volumetric arc therapy dose delivery were utilized. Quality of life (QoL) was evaluated by official translation of EORTC questionnaires (QLQ-C30 and QLQ-BR23). Cosmetics and toxicity were evaluated subjectively and objectively using questionnaires, CTCAE criteria and chest photodocumentation. Economy burden was evaluated at the end of radiotherapy by a 4-point graded scale. In this pilot report we present results of first 30/84 planned patients. Both groups (15 patients in each) were well balanced according to baseline characteristics. Median age 66 years, 66 % invasive ductal carcinoma, 70 % grade 1, median tumor size 9 mm. In SBRT group median PTV volume 52 ccm, minimum PTV dose median 29 Gy, maximum PTV dose median 32 Gy. 6 patients with no dermatitis, 9 patients with grade 1 dermatitis in SBRT group and 8 patients with grade 1, six with grade 2 and one with grade 3 skin toxicity in WBI group at the end of therapy. Significantly less skin sensitivity, dryness, pigmentation and fatigue in SBRT arm comparing to control arm. No differences between groups with respect to acute skin toxicity after 1 and 3 months. No significant difference in questionnaires evaluation. Cosmetic results as well as economic analysis favor SBRT technique. Description of two most common VMAT techniques with evaluation of dose coverage of the target and surrounding tissues parameters will be part of poster presentation. Feasibility, toxicity, cosmetic and financial influence of two radiotherapeutic regiments - the SBRT surgery bed radiotherapy and accelerated whole breast irradiation with the boost to tumor bed were compared. SBRT technique is less toxic and easier feasible approach for adjuvant treatment of selected early-stage breast cancer patients. We add to increase level of evidence for establishment of SBRT in indicated patients into daily clinical practice of APBI.
Read full abstract